Results 121 to 130 of about 122,325 (212)

Short‐Term Clinical Effects After Switching From Zinc Acetate Hydrate to Zinc Histidine Hydrate in Patients With Chronic Liver Disease

Hepatology Research, EarlyView.
Zinc deficiency is frequently seen in patients with chronic liver disease and is linked to poor appetite and nutritional status. We found that switching to zinc histidine hydrate increased zinc levels within a short period and was associated with improved appetite.
Yoshihito Uchida, Naoto Soma, Shohei Tsuji, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida   +9 more
wiley   +1 more source

From Discovery to Cure-Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999-2023). [PDF]

Viruses
Ullah A, Wazir H, Sultany A, Rehman KU, Sultani MI, Khan NA, Khan SA, Ullah MUD, Gondal A.   +8 more
europepmc   +1 more source

Prognostic Value of PALBI in Patients With Hepatocellular Carcinoma and Concurrent Chronic Kidney Disease: A Nomogram Development

Hepatology Research, EarlyView.
Patients with hepatocellular carcinoma (HCC) as well as chronic kidney disease (CKD) are high‐risk individuals, making it challenging to accurately predict their survival. We found that the PALBI grade model when combined with other patient's clinical and tumor‐related factors, forms a new and highly accurate prediction tool to estimate their ...
Jihye Lim, Seok–Hwan Kim, Myeong Jun Song   +2 more
wiley   +1 more source

A Novel Diagnostic Approach for Hepatocellular Carcinoma Using Glycosylated Ferritin

Hepatology Research, EarlyView.
The percentage of glycosylated ferritin relative to total ferritin (%GF) is a novel biomarker for hepatocellular carcinoma (HCC), showing diagnostic performance comparable to that of AFP and DCP. We developed the GFAD index by integrating age, sex, %GF, AFP, and DCP, achieving improved diagnostic accuracy with high sensitivity and specificity. ABSTRACT
Akiyo Ishiguro, Yutaka Suehiro, Issei Saeki, Maho Egusa, Norikazu Tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Yuki Kunimune, Toshihiko Kobayashi, Mitsuaki Nishioka, Taro Takami, Takahiro Yamasaki   +11 more
wiley   +1 more source

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease

Hepatology Research, EarlyView.
ABSTRACT Aim Steatotic liver disease (SLD) encompasses a heterogeneous spectrum with varying risks of hepatocellular carcinoma (HCC). Limited sample sizes limit the development of predictive models, particularly for rare outcomes. This study evaluated whether generative artificial intelligence (AI)‐based synthetic data augmentation can enhance HCC risk
Masaya Sato, Takuma Nakatsuka, Yuki Matsushita, Takuma Kaneko, Keisuke Mabuchi, Tomoharu Yamada, Kazuya Okushin, Tatsuya Minami, Yotaro Kudo, Satoshi Kodera, Kazuhiko Koike, Mitsuhiro Fujishiro, Ryosuke Tateishi   +12 more
wiley   +1 more source

Hepatitis C virus and HIV transmission: parenteral (including percutaneous) routes are still relevant and must receive due attention. [PDF]

Front Public Health
Vento S, Cainelli F.
europepmc   +1 more source

Scaling HIV self‐testing to improve health equity among cisgender gay, bisexual and other men who have sex with men, trans and gender‐diverse people in the United Kingdom: An HIV self‐testing implementation action framework

HIV Medicine, EarlyView.
Abstract Background HIV self‐testing (HIVST) is feasible, highly acceptable and can increase HIV testing uptake/frequency without harm while also reducing costs. Despite HIVST's benefits, UK service provision has been sporadic partially due to policymakers and commissioners' reluctance over concerns about linkage to care/surveillance, which ultimately ...
T. Charles Witzel, Peter Weatherburn, Fiona M. Burns, Isaac Y.‐H. Chu, Phil Samba, Alison J. Rodger   +5 more
wiley   +1 more source

Impact of <i>KIR3DL1/3DS1</i> and <i>HLA-B</i> polymorphisms on hepatitis C virus infection: a case-control study. [PDF]

Front Cell Infect Microbiol
Yin W, Zeng T, Ren C, Chen Y, Guo Y, Ma K, Zhang Y, Yu R, Wang C, Cui J, Huang P, Yue M.   +11 more
europepmc   +1 more source

An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe

HIV Medicine, EarlyView.
Abstract Background Complicated consent procedures for bloodborne virus (HIV, HBV and HCV) testing present barriers to implementation, particularly in non‐specialist healthcare settings. European and global guidelines no longer recommend written consent. An overview of testing consent requirements in Europe is lacking. Methods An online survey on legal
Annemarie Rinder Stengaard, Ann K. Sullivan, Daniel Simões, Josephine Diderichsen, Dorthe Raben, Jürgen K. Rockstroh, on behalf of the EuroTEST Steering Committee, Ann K Sullivan, Ben Collins, Brian Gazzard, Carlos Mejia, Cary James, Casper Rokx, Daniela Rojas Castro, Deniz Gökengin, Ferenc Bagyinszky, Francesco Negro, Igor Karpov, Irith De Baetselier, Jack Lambert, Jens D. Lundgren, Johanna Brännström, Jordi Casabona, Jürgen Rockstroh, Olesia Murha, Lella Cosmaro, Liudmyla Maistat, Loreta Kondili, Magnus Unemo, Maria Prins, Michael Rayment, Milosz Parczewski, Mojca Matičič, Nicoletta Policek, Nikos Dedes, Nino Tsereteli, Olga Grozdetska, Sara Croxford, Tom Platteau, Valerie Delpech, Yazdan Yazdanpanah, Anastasia Pharris, Stela Bivol, Thomas Seyler   +43 more
wiley   +1 more source

A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity. [PDF]

Int J Mol Sci
Nunes GTM, Sant'Anna TBF, de Araujo NM.
europepmc   +1 more source